aquila biolabs, a privately held German technology developer of smart sensors and state-of-the-art data analytics software for bioprocessing applications, today announced that it was acquired by Scientific Bioprocessing, Inc. (SBI), the bioprocess division of Scientific Industries, Inc. (OTCQB: SCND), and developer of optical sensors for non-invasive, real-time monitoring of cell culture systems.
“We are excited to join SBI and expand the reach of our unique platform to bioprocess scientists around the world,” said Daniel Grünes, CEO of aquila biolabs who will assume the role of vice president of R&D and Operations at SBI. “While customers already have access to some process parameters, there are still too many black boxes and unknowns in bioprocessing. Our platform combined with SBI will deliver actionable insights to our customers to help them make the right decisions.”
“As SBI explored the breadth of available technologies that could spearhead digitally simplified bioprocessing, aquila’s approach stood out as the most impressive one,” said Reinhard Vogt, Chairman of SBI and former Executive Vice President and Member of the Board of Sartorius AG. “In addition to a strong pipeline of advanced sensors and data analytics tools, this strategic acquisition adds new talent to our already strong team and expands SBI’s footprint into Europe.”
Founded in 2014, aquila biolabs received Seed and Pre-Series A investments from its investors, Seed Fonds Aachen II, the KfW Bankengruppe, the Qiagen co-founder Dr. Jürgen Schumacher as well as Robert Huber, a professor for bioprocess engineering. “We’ve enjoyed supporting such a fantastic founding team into a successful exit and look forward to seeing the aquila biolabs success story continue,” said Dr. Ansgar Schleicher, Managing Director at TechVision Fonds (formerly Seed Fonds Aachen). After the acquisition, aquila biolabs will continue offering its products and services to researchers and process engineers around the globe from its offices in Baesweiler, Germany. In connection with the acquisition, aquila biolabs has entered into new contracts with its four founders and with Daniela Winzker-Demes, industry veteran and former Vice President of Sales EMEA at Sartorius Lab Instruments, as SBI’s Vice President of Sales EMEA and Asia.
For further information please check out the official Press Release.